[go: up one dir, main page]

Zhang et al., 2020 - Google Patents

An aptamer‐nanotrain assembled from six‐letter DNA delivers doxorubicin selectively to liver cancer cells

Zhang et al., 2020

View PDF
Document ID
9458937791457548126
Author
Zhang L
Wang S
Yang Z
Hoshika S
Xie S
Li J
Chen X
Wan S
Li L
Benner S
Tan W
Publication year
Publication venue
Angewandte Chemie International Edition

External Links

Snippet

Expanding the number of nucleotides in DNA increases the information density of functional DNA molecules, creating nanoassemblies that cannot be invaded by natural DNA/RNA in complex biological systems. Here, we show how six‐letter GACTZP DNA contributes this …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48776—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form forms of ingredients not provided for by groups A61K47/48784 - A61K47/48992, e.g. cells, cell fragments, viruses, ghosts, red blood cells, viral vectors having the pharmacologically or therapeutically active agent complexed or covalently linked to, or being themselves modified by complexation or covalent linkage by a modifying agent

Similar Documents

Publication Publication Date Title
Zhang et al. An aptamer‐nanotrain assembled from six‐letter DNA delivers doxorubicin selectively to liver cancer cells
Zhang et al. Ribbon of DNA lattice on gold nanoparticles for selective drug delivery to cancer cells
Zhou et al. Molecular Engineering‐Based Aptamer–Drug Conjugates with Accurate Tunability of Drug Ratios for Drug Combination Targeted Cancer Therapy
Xue et al. Target‐induced catalytic assembly of Y‐shaped DNA and its application for in situ imaging of MicroRNAs
Xiong et al. DNAzyme‐mediated genetically encoded sensors for ratiometric imaging of metal ions in living cells
Lu et al. Multifunctional DNA origami nanoplatforms for drug delivery
Zhou et al. Cell-specific aptamer-mediated targeted drug delivery
Patel et al. Peptide antisense nanoparticles
Wu et al. Engineering of switchable aptamer micelle flares for molecular imaging in living cells
Boyacioglu et al. Dimeric DNA aptamer complexes for high-capacity–targeted drug delivery using pH-sensitive covalent linkages
Zhu et al. Self‐assembled aptamer‐based drug carriers for bispecific cytotoxicity to cancer cells
Liu et al. Targeted cell–cell interactions by DNA nanoscaffold‐templated multivalent bispecific aptamers
Bi et al. Target-catalyzed DNA four-way junctions for CRET imaging of microRNA, concatenated logic operations, and self-assembly of DNA nanohydrogels for targeted drug delivery
Zhu et al. Nucleic acid aptamer‐mediated drug delivery for targeted cancer therapy
Qiao et al. Simultaneous detection of intracellular tumor mRNA with bi‐color imaging based on a gold nanoparticle/molecular beacon
Hong et al. Dendrimeric siRNA for efficient gene silencing
Lei et al. Nature-inspired smart DNA nanodoctor for activatable in vivo cancer imaging and in situ drug release based on recognition-triggered assembly of split aptamer
Kumar et al. Advanced selection methodologies for DNAzymes in sensing and healthcare applications
Lei et al. DNA nanotriangle-scaffolded activatable aptamer probe with ultralow background and robust stability for cancer theranostics
Meng et al. Cell-SELEX-based aptamer-conjugated nanomaterials for cancer diagnosis and therapy
Kye et al. Reciprocal Self‐Assembly of Peptide–DNA Conjugates into a Programmable Sub‐10‐nm Supramolecular Deoxyribonucleoprotein
Xu et al. Continuously tunable nucleotide/lanthanide coordination nanoparticles for DNA adsorption and sensing
US20160159834A1 (en) Alkyne phosphoramidites and preparation of spherical nucleic acid constructs
Fritz et al. Orthogonal click conjugation to the liposomal surface reveals the stability of the lipid anchorage as crucial for targeting
Tian et al. Nucleic acid–based aggregates and their biomedical applications